Y chromosome loss in cancer drives growth by evasion of adaptive immunityHany Abdel-Hafiz, Dan Theodorescu, Xingyu Chen et al.|Nature|2023Cited by 175
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapyMegan M. Tu, Dan Theodorescu, Jonathan Kaye et al.|Communications Biology|2020Cited by 170
The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and TransrepressionHany Abdel-Hafiz, Kathryn B. Horwitz, Lin Tung et al.|Journal of Biological Chemistry|2002Cited by 146
Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapyMegan M. Tu, Dan Theodorescu, Abigail K. Kimball et al.|Science Advances|2019Cited by 126
Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesteroneMarius C. Jones, Jan J. Brosens, Jenny H. Higham et al.|Proceedings of the National Academy of Sciences|2006Cited by 115